Report Detail

Pharma & Healthcare Global Metformin API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4517191
  • |
  • 27 February, 2023
  • |
  • Global
  • |
  • 105 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Metformin API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Metformin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Metformin API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Metformin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Metformin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Metformin API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Metformin API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Metformin API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma and Keyuan Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Metformin API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
99% or More
Less than 99%
Market segment by Application
Tablet
Capsule
Major players covered
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Metformin API, with price, sales, revenue and global market share of Metformin API from 2018 to 2023.
Chapter 3, the Metformin API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Metformin API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Metformin API.
Chapter 14 and 15, to describe Metformin API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Metformin API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Metformin API Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 99% or More
    • 1.3.3 Less than 99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Metformin API Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Tablet
    • 1.4.3 Capsule
  • 1.5 Global Metformin API Market Size & Forecast
    • 1.5.1 Global Metformin API Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Metformin API Sales Quantity (2018-2029)
    • 1.5.3 Global Metformin API Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Wanbury
    • 2.1.1 Wanbury Details
    • 2.1.2 Wanbury Major Business
    • 2.1.3 Wanbury Metformin API Product and Services
    • 2.1.4 Wanbury Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Wanbury Recent Developments/Updates
  • 2.2 USV
    • 2.2.1 USV Details
    • 2.2.2 USV Major Business
    • 2.2.3 USV Metformin API Product and Services
    • 2.2.4 USV Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 USV Recent Developments/Updates
  • 2.3 Shouguang Fukang Pharmaceutical
    • 2.3.1 Shouguang Fukang Pharmaceutical Details
    • 2.3.2 Shouguang Fukang Pharmaceutical Major Business
    • 2.3.3 Shouguang Fukang Pharmaceutical Metformin API Product and Services
    • 2.3.4 Shouguang Fukang Pharmaceutical Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Shouguang Fukang Pharmaceutical Recent Developments/Updates
  • 2.4 Vistin Pharma
    • 2.4.1 Vistin Pharma Details
    • 2.4.2 Vistin Pharma Major Business
    • 2.4.3 Vistin Pharma Metformin API Product and Services
    • 2.4.4 Vistin Pharma Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Vistin Pharma Recent Developments/Updates
  • 2.5 Keyuan Pharmaceutical
    • 2.5.1 Keyuan Pharmaceutical Details
    • 2.5.2 Keyuan Pharmaceutical Major Business
    • 2.5.3 Keyuan Pharmaceutical Metformin API Product and Services
    • 2.5.4 Keyuan Pharmaceutical Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Keyuan Pharmaceutical Recent Developments/Updates
  • 2.6 Farmhispania Group
    • 2.6.1 Farmhispania Group Details
    • 2.6.2 Farmhispania Group Major Business
    • 2.6.3 Farmhispania Group Metformin API Product and Services
    • 2.6.4 Farmhispania Group Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Farmhispania Group Recent Developments/Updates
  • 2.7 Harman Finochem
    • 2.7.1 Harman Finochem Details
    • 2.7.2 Harman Finochem Major Business
    • 2.7.3 Harman Finochem Metformin API Product and Services
    • 2.7.4 Harman Finochem Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Harman Finochem Recent Developments/Updates
  • 2.8 Shijiazhuang Polee Pharmaceutical
    • 2.8.1 Shijiazhuang Polee Pharmaceutical Details
    • 2.8.2 Shijiazhuang Polee Pharmaceutical Major Business
    • 2.8.3 Shijiazhuang Polee Pharmaceutical Metformin API Product and Services
    • 2.8.4 Shijiazhuang Polee Pharmaceutical Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Shijiazhuang Polee Pharmaceutical Recent Developments/Updates
  • 2.9 Aarti Drugs
    • 2.9.1 Aarti Drugs Details
    • 2.9.2 Aarti Drugs Major Business
    • 2.9.3 Aarti Drugs Metformin API Product and Services
    • 2.9.4 Aarti Drugs Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Aarti Drugs Recent Developments/Updates
  • 2.10 Exemed Pharmaceuticals
    • 2.10.1 Exemed Pharmaceuticals Details
    • 2.10.2 Exemed Pharmaceuticals Major Business
    • 2.10.3 Exemed Pharmaceuticals Metformin API Product and Services
    • 2.10.4 Exemed Pharmaceuticals Metformin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Exemed Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Metformin API by Manufacturer

  • 3.1 Global Metformin API Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Metformin API Revenue by Manufacturer (2018-2023)
  • 3.3 Global Metformin API Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Metformin API by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Metformin API Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Metformin API Manufacturer Market Share in 2022
  • 3.5 Metformin API Market: Overall Company Footprint Analysis
    • 3.5.1 Metformin API Market: Region Footprint
    • 3.5.2 Metformin API Market: Company Product Type Footprint
    • 3.5.3 Metformin API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Metformin API Market Size by Region
    • 4.1.1 Global Metformin API Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Metformin API Consumption Value by Region (2018-2029)
    • 4.1.3 Global Metformin API Average Price by Region (2018-2029)
  • 4.2 North America Metformin API Consumption Value (2018-2029)
  • 4.3 Europe Metformin API Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Metformin API Consumption Value (2018-2029)
  • 4.5 South America Metformin API Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Metformin API Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Metformin API Sales Quantity by Type (2018-2029)
  • 5.2 Global Metformin API Consumption Value by Type (2018-2029)
  • 5.3 Global Metformin API Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Metformin API Sales Quantity by Application (2018-2029)
  • 6.2 Global Metformin API Consumption Value by Application (2018-2029)
  • 6.3 Global Metformin API Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Metformin API Sales Quantity by Type (2018-2029)
  • 7.2 North America Metformin API Sales Quantity by Application (2018-2029)
  • 7.3 North America Metformin API Market Size by Country
    • 7.3.1 North America Metformin API Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Metformin API Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Metformin API Sales Quantity by Type (2018-2029)
  • 8.2 Europe Metformin API Sales Quantity by Application (2018-2029)
  • 8.3 Europe Metformin API Market Size by Country
    • 8.3.1 Europe Metformin API Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Metformin API Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Metformin API Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Metformin API Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Metformin API Market Size by Region
    • 9.3.1 Asia-Pacific Metformin API Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Metformin API Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Metformin API Sales Quantity by Type (2018-2029)
  • 10.2 South America Metformin API Sales Quantity by Application (2018-2029)
  • 10.3 South America Metformin API Market Size by Country
    • 10.3.1 South America Metformin API Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Metformin API Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Metformin API Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Metformin API Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Metformin API Market Size by Country
    • 11.3.1 Middle East & Africa Metformin API Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Metformin API Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Metformin API Market Drivers
  • 12.2 Metformin API Market Restraints
  • 12.3 Metformin API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Metformin API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Metformin API
  • 13.3 Metformin API Production Process
  • 13.4 Metformin API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Metformin API Typical Distributors
  • 14.3 Metformin API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Metformin API. Industry analysis & Market Report on Metformin API is a syndicated market report, published as Global Metformin API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Metformin API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,735.28
    4,102.92
    5,470.56
    3,208.56
    4,812.84
    6,417.12
    547,369.20
    821,053.80
    1,094,738.40
    290,475.60
    435,713.40
    580,951.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report